GB201602621D0 - Antibodies for treatment and diagnosis of inflammatory bowel disease - Google Patents

Antibodies for treatment and diagnosis of inflammatory bowel disease

Info

Publication number
GB201602621D0
GB201602621D0 GBGB1602621.3A GB201602621A GB201602621D0 GB 201602621 D0 GB201602621 D0 GB 201602621D0 GB 201602621 A GB201602621 A GB 201602621A GB 201602621 D0 GB201602621 D0 GB 201602621D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
diagnosis
treatment
inflammatory bowel
bowel disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1602621.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philogen SpA
Original Assignee
Philogen SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philogen SpA filed Critical Philogen SpA
Priority to GBGB1602621.3A priority Critical patent/GB201602621D0/en
Publication of GB201602621D0 publication Critical patent/GB201602621D0/en
Priority to CA3045203A priority patent/CA3045203A1/en
Priority to PCT/EP2016/080462 priority patent/WO2017097990A1/en
Priority to US16/060,766 priority patent/US10647760B2/en
Priority to JP2018530133A priority patent/JP6746701B2/en
Priority to AU2016368529A priority patent/AU2016368529A1/en
Priority to EP16820184.6A priority patent/EP3387016A1/en
Ceased legal-status Critical Current

Links

GBGB1602621.3A 2015-12-11 2016-02-15 Antibodies for treatment and diagnosis of inflammatory bowel disease Ceased GB201602621D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB1602621.3A GB201602621D0 (en) 2016-02-15 2016-02-15 Antibodies for treatment and diagnosis of inflammatory bowel disease
CA3045203A CA3045203A1 (en) 2015-12-11 2016-12-09 Antibodies for treatment and diagnosis of inflammatory bowel disease
PCT/EP2016/080462 WO2017097990A1 (en) 2015-12-11 2016-12-09 Antibodies for treatment and diagnosis of inflammatory bowel disease
US16/060,766 US10647760B2 (en) 2015-12-11 2016-12-09 Antibodies for treatment and diagnosis of inflammatory bowel disease
JP2018530133A JP6746701B2 (en) 2015-12-11 2016-12-09 Antibodies for treatment and diagnosis of inflammatory bowel disease
AU2016368529A AU2016368529A1 (en) 2015-12-11 2016-12-09 Antibodies for treatment and diagnosis of inflammatory bowel disease
EP16820184.6A EP3387016A1 (en) 2015-12-11 2016-12-09 Antibodies for treatment and diagnosis of inflammatory bowel disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1602621.3A GB201602621D0 (en) 2016-02-15 2016-02-15 Antibodies for treatment and diagnosis of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
GB201602621D0 true GB201602621D0 (en) 2016-03-30

Family

ID=55697683

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1602621.3A Ceased GB201602621D0 (en) 2015-12-11 2016-02-15 Antibodies for treatment and diagnosis of inflammatory bowel disease

Country Status (1)

Country Link
GB (1) GB201602621D0 (en)

Similar Documents

Publication Publication Date Title
EP2971127A4 (en) Methods for the diagnosis and treatment of inflammatory bowel disease
IL277217A (en) Use of anti-il-36r antibodies for treatment of inflammatory bowel disease
IL246917B (en) Biomarker and methods for early diagnosis of alzheimer's disease
IL276516A (en) Methods for diagnosing and treating inflammatory bowel disease
IL256685B (en) Isolated tau-binding antibody and use thereof for treatment and diagnosis of a tauopathy
GB201504432D0 (en) Materials and methods for diagnosis and treatment of alzheimers disease
EP3430172A4 (en) Methods of diagnosing inflammatory bowel disease through rnaset2
HUE055913T2 (en) Methods and compositions for diagnosis and treatment of glioblastoma
IL275368B (en) Diagnosis and treatment of autoimmune disease
HK1251265A1 (en) Diagnosis and treatment of infectious disease
GB201413357D0 (en) Antibodies for treatment and diagnosis
ZA201906980B (en) Medical use of artemisinin derivative for treating inflammatory bowel disease
GB201618424D0 (en) Treatment of antibody mediated disease
EP3137907A4 (en) Methods and compositions for the diagnosis and treatment of kawasaki disease
MA39950A (en) 2-ACYLAMINOTHIAZOLE DERIVATIVE FOR THE TREATMENT OF URINARY TRACT AND BLADDER DISEASES
EP3602041A4 (en) Methods for diagnosing and treating inflammatory bowel disease
HK1255691A1 (en) Methods for histological diagnosis and treatment of diseases
GB201515244D0 (en) Treatment of inflammatory disease or condition
IL260987A (en) Treatment and diagnosis of inflammatory disorders
IL272604A (en) Methods and compositions for treatment of inflammatory bowel disease
HK1251021A1 (en) Diagnosis and treatment of mers-related renal disease
GB201500875D0 (en) Antibodies for treatment and diagnosis
GB201602621D0 (en) Antibodies for treatment and diagnosis of inflammatory bowel disease
GB201521918D0 (en) Antibodies for treatment and diagnosis of inflammatory bowel disease
HK1222400A1 (en) Use of anti-eotaxin antibodies for treating inflammatory bowel disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)